Clinical Trials Logo

Clinical Trial Summary

The purpose of this study is to evaluate the efficacy and safety of repeated doses of a low dosage of oromucosal Ibuprofen form (lozenge) versus placebo in patients suffering from acute sore throat pain.


Clinical Trial Description

n/a


Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment


Related Conditions & MeSH terms


NCT number NCT01785862
Study type Interventional
Source Pierre Fabre Medicament
Contact
Status Completed
Phase Phase 3
Start date February 2013
Completion date June 2013

See also
  Status Clinical Trial Phase
Completed NCT01535079 - Acute Sore Throat Pain Study Phase 2